Plus Therapeutics
PSTV
8 hedge funds and large institutions have $168K invested in Plus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14% more funds holding
Funds holding: 7 → 8 (+1)
13% more capital invested
Capital invested by funds: $149K → $168K (+$19K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$51.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$5.16K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $129K | +$51.6K | +10 | +56% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10K | +$10.3K | +2 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $9K | +$5.16K | +1 | +100% |
|
4
BlackRock
New York
| $6K | – | – | – |
|
5
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $5K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $4K | +$5.16K | +1 | New |
|
7
Geode Capital Management
Boston,
Massachusetts
| $3K | – | – | – |
|
|
MOS
8
MGO One Seven
Beachwood,
Ohio
| $2K | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3 | – | – | – |
|
|
VF
10
Virtu Financial
New York
| – | -$36K | -8 | Closed |
|
PSTV Hedge Fund Activity: Q2 2019 in Review
8 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2019, worth a combined $168K — up 13% from $149K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PSTV positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $51.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $36K sold.
- 8 institutional investors held Plus Therapeutics (PSTV) as of Q2 2019, up from 7 in Q1 2019.
- Funds reported $168K of Plus Therapeutics stock for Q2 2019, up 13% quarter-over-quarter.
- 2 funds opened new Plus Therapeutics positions in Q2 2019 and 1 closed out, a net change of +1 holder.
- The largest Plus Therapeutics buyer in Q2 2019 was Renaissance Technologies, an estimated $51.6K added.
- The largest Plus Therapeutics seller in Q2 2019 was Virtu Financial, an estimated $36K sold.
Based on aggregated 13F filings for Q2 2019.